106 related articles for article (PubMed ID: 7747464)
21. Accell particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses.
Haynes JR; Fuller DH; Eisenbraun MD; Ford MJ; Pertmer TM
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S43-5. PubMed ID: 7865332
[TBL] [Abstract][Full Text] [Related]
22. Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles.
Sundbäck M; Douagi I; Dayaraj C; Forsell MN; Nordström EK; McInerney GM; Spångberg K; Tjäder L; Bonin E; Sundström M; Liljeström P; Karlsson Hedestam GB
Virology; 2005 Oct; 341(2):190-202. PubMed ID: 16098555
[TBL] [Abstract][Full Text] [Related]
23. Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses.
Gzyl J; Bolesta E; Wierzbicki A; Kmieciak D; Naito T; Honda M; Komuro K; Kaneko Y; Kozbor D
Virology; 2004 Jan; 318(2):493-506. PubMed ID: 14972518
[TBL] [Abstract][Full Text] [Related]
24. Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model.
Liu F; Mboudjeka I; Shen S; Chou TH; Wang S; Ross TM; Lu S
Vaccine; 2004 Apr; 22(13-14):1764-72. PubMed ID: 15068860
[TBL] [Abstract][Full Text] [Related]
25. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
Akahata W; Yang ZY; Nabel GJ
J Virol; 2005 Jan; 79(1):626-31. PubMed ID: 15596858
[TBL] [Abstract][Full Text] [Related]
26. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles.
Akahata W; Ido E; Shimada T; Katsuyama K; Yamamoto H; Uesaka H; Ui M; Kuwata T; Takahashi H; Hayami M
Virology; 2000 Sep; 275(1):116-24. PubMed ID: 11017793
[TBL] [Abstract][Full Text] [Related]
27. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting.
Richmond JF; Lu S; Santoro JC; Weng J; Hu SL; Montefiori DC; Robinson HL
J Virol; 1998 Nov; 72(11):9092-100. PubMed ID: 9765454
[TBL] [Abstract][Full Text] [Related]
28. Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina.
Galvin TA; Muller J; Khan AS
Vaccine; 2000 May; 18(23):2566-83. PubMed ID: 10775791
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.
Green TD; Montefiori DC; Ross TM
J Virol; 2003 Feb; 77(3):2046-55. PubMed ID: 12525639
[TBL] [Abstract][Full Text] [Related]
30. Induction of humoral and cellular immune responses in mice by HIV-derived infectious pseudovirions.
Racek T; Jármy G; Jassoy C
AIDS Res Hum Retroviruses; 2006 Nov; 22(11):1162-6. PubMed ID: 17147504
[TBL] [Abstract][Full Text] [Related]
31. Detection of IgG anti-HIV antibodies in mice experimentally infected with HIV-1.
Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
Microbiologica; 1989 Jan; 12(1):75-80. PubMed ID: 2716538
[TBL] [Abstract][Full Text] [Related]
32. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1.
Sasaki S; Tsuji T; Hamajima K; Fukushima J; Ishii N; Kaneko T; Xin KQ; Mohri H; Aoki I; Okubo T; Nishioka K; Okuda K
Infect Immun; 1997 Sep; 65(9):3520-8. PubMed ID: 9284115
[TBL] [Abstract][Full Text] [Related]
33. Evolution of neutralizing antibody response against HIV type 1 virions and pseudovirions in multicenter AIDS cohort study participants.
Quinnan GV; Zhang PF; Fu DW; Dong M; Margolick JB
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):939-49. PubMed ID: 9686640
[TBL] [Abstract][Full Text] [Related]
34. Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain.
Ye L; Bu Z; Vzorov A; Taylor D; Compans RW; Yang C
J Virol; 2004 Dec; 78(24):13409-19. PubMed ID: 15564451
[TBL] [Abstract][Full Text] [Related]
35. Preservation of surface-dependent properties of viral antigens following immobilization on particulate ceramic delivery vehicles.
Kossovsky N; Gelman A; Sponsler E; Rajguru S; Torres M; Mena E; Ly K; Festekjian A
J Biomed Mater Res; 1995 May; 29(5):561-73. PubMed ID: 7622541
[TBL] [Abstract][Full Text] [Related]
36. Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo.
Flamar AL; Contreras V; Zurawski S; Montes M; Dereuddre-Bosquet N; Martinon F; Banchereau J; Le Grand R; Zurawski G; Levy Y
PLoS One; 2015; 10(9):e0135513. PubMed ID: 26407317
[TBL] [Abstract][Full Text] [Related]
37. Production of immunogenic HIV-1 viruslike particles in stably engineered monkey cell lines.
Haynes JR; Cao SX; Rovinski B; Sia C; James O; Dekaban GA; Klein MH
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):17-27. PubMed ID: 1707639
[TBL] [Abstract][Full Text] [Related]
38. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans.
Ugen KE; Nyland SB; Boyer JD; Vidal C; Lera L; Rasheid S; Chattergoon M; Bagarazzi ML; Ciccarelli R; Higgins T; Baine Y; Ginsberg R; Macgregor RR; Weiner DB
Vaccine; 1998 Nov; 16(19):1818-21. PubMed ID: 9795386
[TBL] [Abstract][Full Text] [Related]
39. Genetic control of immune responses to HIV-1 env DNA vaccine.
Ishii N; Sugita Y; Nakajima H; Bukawa H; Asakura Y; Okuda K
Microbiol Immunol; 1997; 41(5):421-5. PubMed ID: 9194041
[TBL] [Abstract][Full Text] [Related]
40. Humoral and cell-mediated immunity in rabbits immunized with live non-replicating avipox recombinants expressing the HIV-1SF2 env gene.
Radaelli A; Gimelli M; Cremonesi C; Scarpini C; De Giuli Morghen C
Vaccine; 1994 Sep; 12(12):1110-7. PubMed ID: 7998421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
